drugset / Trial / NCT01906164
Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will assess the safety, tolerability, and pharmacokinetics (PK) of orally administered ALS-008176 in healthy volunteers.
Timeline
- Start
- 2013-05-31
- Primary completion
- 2013-11-30
- Completion
- 2013-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lumicitabine | Small molecule | — | Oral |